AMY STEVENS: Open Payments
NPI 1982699955 · NASHVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 74 payments from 16 companies in 2025. Trend: 2023 $660 · 2024 $559 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $215 |
| Incyte Corporation | 16 | $180 |
| Galderma Laboratories, L.P. | 13 | $158 |
| Lilly USA, LLC | 7 | $120 |
| UCB, Inc. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Organon LLC | 6 | $60 |
| Amgen Inc. | 3 | $55 |
| GENZYME CORPORATION | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
Products named: OPZELURA, NEMLUVIO, SKYRIZI, Bimzelx, COSENTYX, RINVOQ, TALTZ, OTEZLA.
Industry payments across IL — which companies pay providers there.
